Reports for AA PHARMA INC

Company Name
AA PHARMA INC

Shortage reports

Actual shortage:

25 (5%)

Anticipated shortage:

0 (0%)

Avoided shortage:

6 (1%)

Resolved:

462 (94%)

493

Discontinuation Reports

To be discontinued:

9 (15%)

Discontinued:

51 (82%)

Reversed:

2 (3%)

62

31 (6%)

24 (71%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
KETOROLAC 0.5% SOLUTION Resolved 2023-03-30 2023-06-13 188326
KETOROLAC 0.5% SOLUTION Resolved 2023-03-08 2023-06-13 186515
KETOROLAC 0.5% SOLUTION Resolved 2022-07-27 2022-08-25 165600
LITHMAX 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-07 2024-01-20 212786
LITHMAX 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-11 2024-08-06 221857
LITHMAX 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-07-04 2025-12-08 261865
LITHMAX 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-12-18 2026-01-02 274575
LORAZEPAM SUBLINGUAL 1MG TABLET Resolved 2023-02-28 2023-05-01 185682
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-05-11 2023-07-15 192270
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2025-09-10 2025-09-24 266909
LORAZEPAM SUBLINGUAL 1MG TABLET Resolved 2021-09-09 2021-09-30 145410
LORAZEPAM SUBLINGUAL 0.5MG TABLET Resolved 2023-02-03 2023-04-17 183599
LOVASTATIN 40MG TABLET Resolved 2025-03-19 2025-05-01 253032
MEFENAMIC 250MG CAPSULE Resolved 2025-02-06 2025-03-19 249651
MEFENAMIC 250MG CAPSULE Resolved 2024-10-18 2024-12-11 240624
MEFENAMIC 250MG CAPSULE Resolved 2024-07-31 2024-09-05 234154
MEFENAMIC 250MG CAPSULE Resolved 2023-11-15 2024-01-31 210273
MEFENAMIC 250MG CAPSULE Resolved 2021-07-08 2021-07-14 142026
MEFLOQUINE 250MG TABLET Resolved 2023-08-23 2023-09-14 202753
MEGESTROL 40MG TABLET Resolved 2024-06-12 2025-04-04 230221

Showing 321 to 340 of 493

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRIHEXYPHENIDYL 2MG TABLET Reversed 2018-12-20 2019-07-22 70209
TRIMIPRAMINE 25MG TABLET Discontinued 2017-03-28 2017-03-28 4528

Showing 61 to 62 of 62